ΠΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΡ Π³ΠΈΠ±Π΅Π»ΠΈ ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΏΡΠΈ Π΄Π΅ΠΉΡΡΠ²ΠΈΠΈ Π½ΠΎΠ²ΡΡ ΡΠ³Π»Π΅Π²ΠΎΠ΄Π½ΡΡ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΡ ΠΈΠ½Π΄ΠΎΠ»ΠΎΠΊΠ°ΡΠ±Π°Π·ΠΎΠ»ΠΎΠ²
Π’Π°ΠΊΠΈΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠΌ, ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΠ΅ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΠΎΠ² Π³ΠΈΠ±Π΅Π»ΠΈ ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΏΡΠΈ Π΄Π΅ΠΉΡΡΠ²ΠΈΠΈ ΠΈΠ½Π΄ΠΎΠ»ΠΎΠΊΠ°ΡΠ±Π°Π·ΠΎΠ»ΠΎΠ² ΠΈ ΠΈΡ ΡΠ³Π»Π΅Π²ΠΎΠ΄ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΡ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΡ Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΠΎ Π΄Π»Ρ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΠΎΠ³ΠΎ ΠΏΠΎΠΈΡΠΊΠ° ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΡ , ΠΎΠ±Π»Π°Π΄Π°ΡΡΠΈΡ ΠΏΡΠΈΠ΅ΠΌΠ»Π΅ΠΌΡΠΌΠΈ ΠΏΡΠΎΡΠΈΠ²ΠΎΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΠΌΠΈ ΡΠ²ΠΎΠΉΡΡΠ²Π°ΠΌΠΈ ΠΈ ΠΌΠ΅Π½ΡΡΠ΅ΠΉ ΠΎΠ±ΡΠ΅ΡΠ΅Π·ΠΎΡΠ±ΡΠΈΠ²Π½ΠΎΠΉ ΡΠΎΠΊΡΠΈΡΠ½ΠΎΡΡΡΡ. ΠΡΠΎΡ ΠΏΡΠΈΠΊΠ»Π°Π΄Π½ΠΎΠΉ Π°ΡΠΏΠ΅ΠΊΡ Π΄ΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΠΈ Π±Π°Π·ΠΈΡΡΠ΅ΡΡΡ Π½Π° ΡΡΠ½Π΄Π°ΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠΌ Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΠΎΠ² Π³ΠΈΠ±Π΅Π»ΠΈ ΠΊΠ»Π΅ΡΠΎΠΊ ΡΡΠΊΠ°ΡΠΈΠΎΡ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΠ»Π°Π²Π° 1. ΠΠΠΠΠ ΠΠΠ’ΠΠ ΠΠ’Π£Π Π«
- ΠΠ»Π°Π²Π° 2. ΠΠΠ’ΠΠ ΠΠΠΠ« Π ΠΠΠ’ΠΠΠ« ΠΠ‘Π‘ΠΠΠΠΠΠΠΠΠ―
- ΠΠ»Π°Π²Π° 3. Π ΠΠΠ£ΠΠ¬Π’ΠΠ’Π« ΠΠ‘Π‘ΠΠΠΠΠΠΠΠΠ―
- ΠΠ»Π°Π²Π° 4. ΠΠΠ‘Π£ΠΠΠΠΠΠ
- ΠΠ»Π°Π²Π° 5. ΠΠ«ΠΠΠΠ«
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- Prasad S. h ap. Intermediate filament proteins during carcinogenesis and apoptosis (Review) // Int. J. Oncol. 1999. № 14. C. 563−570.
- Zou H. h Ap. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9 //J. Biol. Chem. 1999. № 274. C. 11 549−11 556.
- Rane S.G. h ap. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia // Nat. Genet. 1999. № 22. C. 44−52.
- Shimizu S., Narita M., Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC // Nature. 1999. № 399. C. 483−487.
- Luo G. h Ap. Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation // Proc. Natl. Acad. Sci. U.S.A. 1999. № 96. C. 7376−7381.
- Gille H., Downward J. Multiple ras effector pathways contribute to G (l) cell cycle progression // J. Biol. Chem. 1999. № 274. C. 22 033−22 040.
- Yoshinari T. h ap. Mode of action of a new indolocarbazole anticancer agent, J-10 708 8, targeting topoisomerase I // Cancer Res. 1999. № 59. C. 4271−4275.
- Sionov R.V., Haupt Y. The cellular response to p53: the decision between life and death // Oncogene. 1999. № 18. C. 6145−6157.
- Orlov S.N. h ap. Purinergic modulation of Na (+), K (+), C1(-) cotransport and MAP kinases is limited to CI 1-MDCK cells resembling intercalated cells from collecting ducts // J. Membr. Biol.1999. № 172. C. 225−234.
- Khosravi R. h AP- Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage // Proc. Natl. Acad. Sci. U.S.A. 1999. № 96. C. 14 973−14 977.
- Antonsson B. h ap. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria // Biochem. J. 2000. № 345 Pt 2. C. 271−278.
- Wang X.K. Calpain and caspase: can you tell the difference? // Trends Neurosci. 2000. № 23. C. 20−26.
- Bailly C. Topoisomerase T poisons and suppressors as anticancer drugs // Curr. Med. Chem.2000. № 7. C. 39−58.
- Tenjo T. h zip. Prognostic significance of p27(kip 1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas // Oncology. 2000. № 58. C. 45−51.
- Chehab N.H. h zip. Chk2/hCdsl functions as a DNA damage checkpoint in G (l) by stabilizing p53 // Genes Dev. 2000. № 14. C. 278−288.
- Bodmer J.L. h Ap. TRAIL receptor-2 signals apoptosis through FADD and caspase-8 // Nat. Cell Biol. 2000. № 2. C. 241−243.
- Latres E. h np. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis // EMBO J. 2000. № 19. C. 3496−3506.
- Melchionna R. h zip. Threonine 68 is required for radiation-induced phosphorylation and activation of Cdsl // Nat. Cell Biol. 2000. № 2. C. 762−765.
- Nakanishi M. h ap. Identification and characterization of human Wee 1B, a new member of the Weel family of Cdk-inhibitory kinases // Genes Cells. 2000. № 5. C. 839−847.
- Prudhomme M. Recent developments of rebeccamycin analogues as topoisomerase 1 inhibitors and antitumor agents // Curr. Med. Chem. 2000. № 7. C. 1189−1212.
- Tong X. h flp. Cleavage of ATM during radiation-induced apoptosis: caspase-3-like apoptotic protease as a candidate // Int. J. Radiat. Biol. 2000. № 76. C. 1387−1395.
- Schmelzle T., Hall M.N. TOR, a central controller of cell growth // Cell. 2000. № 103. C. 253−262.
- Teter S.A. h zip. Degradation of lipid vesicles in the yeast vacuole requires function of Cvtl7, a putative lipase//J. Biol. Chem. 2001. № 276. C. 2083−2087.
- Sperandio S., de Belle I., Bredesen D.E. An alternative, nonapoptotic form of programmed cell death//Proc. Natl. Acad. Sci. U.S.A. 2000. № 97. C. 14 376−14 381.
- Matsumura H. h AP- Necrotic death pathway in Fas receptor signaling // J. Cell Biol. 2000. № 151. C. 1247−1256.
- Jeffrey P.D., Tong L., Pavletich N.P. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors//Genes Dev. 2000. № 14. C. 3115−3125.
- Stewart M.J., Steenkamp V. The biochemistry and toxicity of atractyloside: a review // Ther Drug Monit. 2000. № 22. C. 641−649.
- Kihara A. h ap. Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae // J. Cell Biol. 2001. № 152. C. 519−530.
- Urasaki Y. h, ap. Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site // Cancer Res. 2001. № 61. C. 504−508.
- Propper D.J. h, ap. Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C// J. Clin. Oncol. 2001. № 19. C. 1485−1492.
- Zhu J. h ap. Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice // Curr. Biol. 2001. № 11. C. 105−109.
- Los M.'h Ap. Caspases: more than just killers? // Trends Immunol. 2001. № 22. C. 31−34.
- Makiniemi M. h aP- BRCT domain-containing protein TopBPl functions in DNA replication and damage response //J. Biol. Chem. 2001. № 276. C. 30 399−30 406.
- Pathan N. h ap. TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer//J. Biol. Chem. 2001. № 276. C. 32 220−32 229.
- Kannan K. h zip. DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-I // Oncogene. 2001. № 20. C. 3449−3455.
- Guo K. h Ap. Hypoxia induces the expression of the pro-apoptotic gene BNIP3 // Cell Death Differ. 2001. № 8. C. 367−376.
- Cain K. h flp. Physiological concentrations of K+ inhibit cytochrome c-dependent formation of the apoptosome // J. Biol. Chem. 2001. № 276. C. 41 985−41 990.
- Burma S. h ap. ATM phosphorylates histone H2AX in response to DNA double-strand breaks // J. Biol. Chem. 2001. № 276. C. 42 462−42 467.
- Reimertz C. h, ap. Ca (2+)-induced inhibition of apoptosis in human SH-SY5Y neuroblastoma cells: degradation of apoptotic protease activating factor-1 (APAF-1) // J. Neurochem. 2001. № 78. C. 1256−1266.
- Sherr C.J. The INK4a/ARF network in tumour suppression // Nat. Rev. Mol. Cell Biol. 2001. № 2. C. 731−737.
- Hirabayashi M. h np. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration // Cell Death Differ. 2001. № 8. C. 977
- Cortez D. h ap. ATRand ATRIP: partners in checkpoint signaling // Science. 2001. № 294. C. 1713−1716.
- Jin S., Levine A.J. The p53 functional circuit//J. Cell. Sci. 2001. № 114. C. 4139−4140.
- Pastorino J.G., ShulgaN., Hoek J.B. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis // J. Biol. Chem. 2002. № 277. C. 7610−7618.
- Talloczy Z. h ap- Regulation of starvation- and virus-induccd autophagy by the eIF2alpha kinase signaling pathway // Proc. Natl. Acad. Sci. U.S.A. 2002. № 99. C. 190−195.
- Ermak G., Davies K.J.A. Calcium and oxidative stress: from cell signaling to cell death // Mol. Immunol. 2002. № 38. C. 713−721.
- Budd R.C. Death receptors couple to both cell proliferation and apoptosis // J. Clin. Invest. 2002. № 109. C. 437−441.
- Hirai I., Wang H. A role of the C-terminal region of human Rad9 (hRad9) in nuclear transport of the hRad9 checkpoint complex // J. Biol. Chem. 2002. № 277. C. 25 722−25 727.
- Levis M. h ap. A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo // Blood. 2002. № 99. C. 3885−3891.
- Karran L., Dyer M.J. Proteolytic cleavage of molccules involved in cell death or survival pathways: a role in the control of apoptosis? // Crit. Rev. Eukaryot. Gene Expr. 2001. № 11. C. 269−277.
- Cole K.K., Perez-Polo J.R. Poly (ADP-ribose) polymerase inhibition prevents both apoptotic-like delayed neuronal death and necrosis after H (2)0(2) injury // J. Neurochem. 2002. № 82. C. 19−29.
- Leise W., Mueller P.R. Multiple Cdkl inhibitory kinases regulate the cell cycle during development//Dev. Biol. 2002. № 249. C. 156−173.
- Symington L.S. Role ofRAD52 epistasis group genes in homologous recombination and double-strand break repair// Microbiol. Mol. Biol. Rev. 2002. № 66. C. 630−670, table of contents.
- Gartel A.L., Tyner A.L. The role of the eye 1 in-dependent kinase inhibitor p2l in apoptosis // Mol. Cancer Ther. 2002. № 1. C. 639−649.
- Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation // Nature. 2003. № 421. C. 499−506.
- Mihara M. h zip. p53 has a direct apoptogenic role at the mitochondria // Mol. Cell. 2003. № 1 l.C. 577−590.
- Liang J., Slingerland J.M. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression // Cell Cycle. 2003. № 2. C. 339−345.
- Wang C., Klionsky D.J. The molecular mechanism of autophagy // Mol. Med. 2003. № 9. C. 65−76.
- Haupt S. h ap. Apoptosis the p53 network//J. Cell. Sci. 2003. № 116. C. 4077−4085.
- Pagano M. h AP- Cyclin A is required at two points in the human cell cycle // EMBO J. 1992. № 1 l.C. 961−971.
- Berthet C. h pp. Cdk2 knockout mice are viable // Curr. Biol. 2003. № 13. C. 1775−1785.
- Busino L. h ap. Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage //Nature. 2003. № 426. C. 87−91.
- Zou L., Liu D., Elledge S.J. Replication protein A-mediated recruitment and activation of Radl7 complexes // Proc. Natl. Acad. Sci. U.S.A. 2003. № 100. C. 13 827−13 832.
- Reggiori F. h zip. The Atgl-Atgl3 complex regulates Atg9 and Atg23 retrieval transport from the pre-autophagosomal structure // Dev. Cell. 2004. № 6. C. 79−90.
- Eder J.P. h ap. A phase I trial of daily oral 4'- N -benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignancies // Invest New Drugs. 2004. № 22. C. 139−150.
- Murray A.W. Recycling the cell cycle: cyclins revisited // Cell. 2004. № 116. C. 221−234.
- Huang Y., Lu M., Wu H. Antagonizing XIAP-mediated caspase-3 inhibition. Achilles' heel of cancers? // Cancer Cell. 2004. № 5. c. 1−2.
- Monnerat C. h zip. Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer//Ann. Oncol. 2004. № 15. C. 316−323.
- Pichierri P., Rosselli F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways // EMBO J. 2004. № 23. C. 1178−1187.
- Levine B., Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy// Dev. Cell. 2004. № 6. C. 463−477.
- Gozuacik D., Kimchi A. Autophagy as a cell death and tumor suppressor mechanism // Oncogene. 2004. № 23. C. 2891−2906.
- Mimnaugh E.G. h ap. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity // Mol. Cancer Ther. 2004. № 3. C. 551−566.
- Ricci J. h MPΒ¦ Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex 1 of the electron transport chain // Cell. 2004. № 117. C. 773−786.
- Sperandio S. h zip. Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix // Cell Death Differ. 2004. № 11. C. 1066−1075.
- Zhu W., Chen Y., Dutta A. Rereplication by depletion of geminin is seen regardless of p53 status and activates a G2/M checkpoint // Mol. Cell. Biol. 2004. № 24. C. 7140−7150.
- Green D.R., Kroemer G. The pathophysiology of mitochondrial cell death // Science. 2004. № 305. C. 626−629.
- Okada H., Mak T.W. Pathways of apoptotic and non-apoptotic death in tumour cells // Nat. Rev. Cancer. 2004. № 4. C. 592−603.
- Zindy F. h ap. Cyclin A is required in S phase in normal epithelial cells // Biochem. Biophys. Res. Commun. 1992. № 182. C. 1144−1154.
- Stone R.M. h flp. Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412 // Blood. 2005. № 105. C. 54−60.
- Lisby M. h ap. Choreography of the DNA damage response: spatiotemporal relationships among checkpoint and repair proteins // Cell. 2004. № 118. C. 699−713.
- Zalk R. h ap- Oligomeric states of the voltage-dependent anion channel and cytochrome c release from mitochondria// Biochem. J. 2005. № 386. C. 73−83.
- Prudhomme M. Biological targets of antitumor indolocarbazoles bearing a sugar moiety // Curr Med Chem Anticancer Agents. 2004. № 4. C. 509−521.
- Chen L. h Ap. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function // Mol. Cell. 2005. № 17. C. 393−403.
- Kuwana T. h ap. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly // Mol. Cell. 2005. № 17. C. 525−535.
- Watanabe N. h zip. Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Weel via multiple pathways//Proc. Natl. Acad. Sci. U.S.A. 2005. № 102. C. 11 663−11 668.
- Fan T. h ap. Caspase family proteases and apoptosis // Acta Biochim. Biophys. Sin. (Shanghai). 2005. № 37. C. 719−727.
- Yu X. h ap. A structure of the human apoptosome at 12.8 A resolution provides insights into this cell death platform//Structure. 2005. № 13. C. 1725−1735.
- Palmbos P.L., Daley J.M., Wilson T.E. Mutations of the Yku80 C terminus and Xrs2 FHA domain specifically block yeast nonhomologous end joining// Mol. Cell. Biol. 2005. № 25. C. 10 782−10 790.
- Jazayeri A. h ap. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks //Nat. Cell Biol. 2006. № 8. C. 37−45.
- Dupre A., Boyer-Chatenet L., Gautier J. Two-step activation of ATM by DNA and the Mrel 1-Rad50-Nbsl complex //Nat. Struct. Mol. Biol. 2006. № 13. C. 451−457.
- Shiromizu T. h .up. Regulation of mitotic function of Chkl through phosphorylation at novel sites by cyclin-dependent kinase 1 (Cdkl) // Genes Cells. 2006. № 11. C. 477−485.
- Kim J., Minter-Dykhouse K., Chen J. Signaling networks controlled by the MRN complex and MDC1 during early DNA damage responses // Mol. Carcinog. 2006. № 45. C. 403−408.
- Chandra D. h ap. Intracellular nucleotides act as critical prosurvival factors by binding to cytochrome C and inhibiting apoptosome // Cell. 2006. № 125. C. 1333−1346.
- Genovese C. h ap. Cell cycle control and beyond: emerging roles for the retinoblastoma gene family // Oncogene. 2006. № 25. C. 5201−5209.
- Mimnaugh E.G. h ap. Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade // Mol. Cancer Res. 2006. № 4. C. 667−681.
- Martinon F., Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation // Cell Death Differ. 2007. № 14. C. 10−22.
- Engelberg-Kulka H. h .up. Bacterial programmed cell death and multicellular behavior in bacteria// PLoS Genet. 2006. № 2. C. el35.
- Marti A. h Ap- Expression and activity of cell cycle regulators during proliferation and programmed cell death in the mammary gland // Cell Death Differ. 1995. № 2. C. 277−283.
- Robertson M.J. h AP- Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma // J. Clin. Oncol. 2007. № 25. C. 1741−1746.
- Baines C.P. h Ap. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death // Nat. Cell Biol. 2007. № 9. C. 550−555.
- Matsuoka S. h ap- ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage // Science. 2007. № 316. C. 1160−1166.
- Alemayehu A., Fridrichova 1. The MRE11/RAD50/NBS1 complex destabilization in Lynch-syndrome patients // Eur. J. Hum. Genet. 2007. № 15. C. 922−929.
- Karki P. h Ap. Intracellular K (+) inhibits apoptosis by suppressing the Apaf-1 apoptosome formation and subsequent downstream pathways but not cytochrome c release // Cell Death Differ. 2007. № 14. C. 2068−2075.
- Morschhauser F. h ap- A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma // Ann. Oncol. 2008. № 19. C. 247 253.
- Danial N.N. BCL-2 family proteins: critical checkpoints of apoptotic cell death // Clin. Cancer Res. 2007. № 13. C. 7254−7263.
- Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate celL death //Nat. Rev. Mol. Cell Biol. 2008. № 9. C. 47−59.
- Jiang J. h ap. Interplay between bax, reactive oxygen species production, and cardiolipin oxidation during apoptosis // Biochem. Biophys. Res. Commun. 2008. № 368. C. 145−150.
- Oh Y. h ap- Enzastaurin, an oral serine/threonine kinase inhibitor, as second- or third-line therapy of non-small-cell lung cancer // J. Clin. Oncol. 2008. № 26. C. 1135−1141.
- Chipuk J.E., Green D.R. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? // Trends Cell Biol. 2008. № 18. C. 157−164.
- Wei Y., Fan T., Yu M. Inhibitor of apoptosis proteins and apoptosis // Acta Biochim. Biophys. Sin. (Shanghai). 2008. № 40. C. 278−288.
- Buis J. h ap- Mrel 1 nuclease activity has essential roles in DNA repair and genomic stability distinct from ATM activation // Cell. 2008. № 135. C. 85−96.
- Aressy B., Ducommun B. Cell cycle control by the CDC25 phosphatases // Anticancer Agents Med Chem. 2008. № 8. C. 818−824.
- Waltes R. h ap- Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder // Am. J. Hum. Genet. 2009. № 84. C. 605−616.
- Kreisl T.N. h AP- A phase I trial of enzastaurin in patients with recurrent gliomas // Clin. Cancer Res. 2009. № 15. C. 3617−3623.
- Lapenna S., Giordano A. Cell cycle kinases as therapeutic targets for cancer // Nat Rev Drug Discov. 2009. № 8. C. 547−566.
- KurokawaM., Kornbluth S. Caspases and kinases in a death grip // Cell. 2009. № 138. C. 838−854.
- Clarke P.G. Developmental cell death: morphological diversity and multiple mechanisms // Anat. Embryol. 1990. № 181. C. 195−213.
- Bush J.A. h Ap. Production and biological activity of rebeccamycin, a novel antitumor agent // J. Antibiot. 1987. № 40. C. 668−678.
- Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics // Br. J. Cancer. 1972. № 26. C. 239−257.
- Daksis J.I. h ap- Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle // Oncogene. 1994. № 9. C. 3635−3645.
- Albanese C. h ap- Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions //J. Biol. Chem. 1995. № 270. C. 23 589−23 597.
- Mueller P.R. h AP- Mytl: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15 // Science. 1995. № 270. C. 86−90.
- Steiner P. n Ap. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes//EMBO J. 1995. № 14. C. 4814−4826.
- Reynisdottir I. h AP- Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta//Genes Dev. 1995. № 9. C. 1831−1845.
- Deng C. h Ap. Mice lacking p21C! Pl/WAFl undergo normal development, but are defective in G1 checkpoint control // Cell. 1995. № 82. C. 675−684.
- Hirai H. h ap. Novel INK4 proteins, pi 9 and pi 8, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6 // Mol. Cell. Biol. 1995. № 15. C. 2672−2681.
- Gottlieb T.M., Jackson S.P. Protein kinases and DNA damage //Trends Biochem. Sci. 1994. № 19. C. 500−503.
- Nourse J. h, ap. InterIeukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin // Nature. 1994. № 372. C. 570−573.
- Hannon G.J., Beach D. pl5INK4B is a potential effector ofTGF-beta-induced cell cycle arrest//Nature. 1994. № 371. C. 257−261.
- Bates S. h ap- CDK6 (PLST1RE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1 // Oncogene. 1994. № 9. C. 71−79.
- Fesquet D. h ap. The M015 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation ofThrl61 and its homologues//EMBO J. 1993. № 12. C. 3111−3121.
- Solomon M.J., Harper J.W., Shuttleworth J. CAK, the p34cdc2 activating kinase, contains aprotein identical or closely related to p40M015 // EMBO J. 1993. № 12. C. 3133−3142.
- Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death // Cell. 1993. № 74. C. 609−619.
- Orth K. h ap. The CED-3/lCE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin Alii. Biol. Chem. 1996. № 271. C. 16 443−16 446.
- Boulton S.J., Jackson S.P. Saccharomyces cerevisiae Ku70 potentiates illegitimate DNA double-strand break repair and serves as a barrier to error-prone DNA repair pathways // EMBO J. 1996. № 15. C. 5093−5103.
- Pereira E.R. h ap. Structure-activity relationships in a series of substituted indolocarbazoles: topoisomerase I and protein kinase C inhibition and antitumoral and antimicrobial properties//J. Med. Chem. 1996. № 39. C. 4471−4477.
- Sherr C.J. Cancer cell cycles//Science. 1996. № 274. C. 1672−1677.
- Vanags D.M. h ap. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis//J. Biol. Chem. 1996. № 271. C. 31 075−31 085.
- Westwick J.K. h ap. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways // Mol. Cell. Biol. 1997. № 17. C. 13 241 335.
- Yan Y. h ap. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development // Genes Dev. 1997. № 11. C. 973−983.
- Antonsson B. h ap. Inhibition of Bax channel-forming activity by Bcl-2 // Science. 1997. № 277. C. 370−372.
- Sheridan J.P. h ap. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors // Science. 1997. № 277. C. 818−821.
- Zindy F. h ap. Expression of the pl6INK4a tumor suppressor versus other INK4 family members during mouse development and aging // Oncogene. 1997. № 15. C. 203−211.
- Kothakota S. h %p. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis // Science. 1997. № 278. C. 294−298.
- Brancolini C. h ap. Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of beta-catenin // J. Cell Biol. 1997. № 139. C. 759−771.
- Siliciano J.D. h DNA damage induces phosphorylation of the amino terminus of p53 // Genes Dev. 1997. № 11. C. 3471−3481.
- Enari M. h ap- A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD//Nature. 1998. № 391. C. 43:50.
- Schneider P. h up. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB // Immunity. 1997. № 7. C. 831−836.
- Phelps D.E. h ap- Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor pi8INK4c expression during myogenesis//Mol. Cell. Biol. 1998. № 18. C. 2334−2343.
- Brandeis M. h, ap. Cyclin B2-null mice develop normally and are fertile whereas cyclin Bl-null mice die in utero // Proc. Natl. Acad. Sci. U.S.A. 1998. № 95. C. 4344−4349.
- Jiirgensmeier J.M. h ap. Bax directly induces release of cytochrome c from isolated mitochondria // Proc. Natl. Acad. Sci. U.S.A. 1998. № 95. C. 4997−5002.
- Flygare J. h zip. Proteolytic cleavage of HsRad51 during apoptosis // FEBS Lett. 1998. № 427. C. 247−251.
- Luo X. h ap. Bid, a BcI2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors // Cell. 1998. № 94. C. 481 490.
- Li H. h zip. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Faspathway of apoptosis// Cell. 1998. № 94. C. 491−501.
- Schmeiser Π. ΠΈ Π΄Ρ. Specific cleavage of gamma catenin by caspases during apoptosis // FEBS Lett. 1998. № 433. C. 51−57.
- Marzo I. ΠΈ Π΄Ρ. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis // Science. 1998. № 281. C. 2027−2031.
- Esk.es R. ΠΈ Π΄Ρ. Bax-induced cytochrome Π‘ release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions // J. Cell Biol. 1998. № 143. C. 217−224.
- Bennett M. ΠΈ Π΄Ρ. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis // Science. 1998. № 282. C. 290−293.
- Jeggo P.A. Identification of genes involved in repair of DNA double-strand breaks in mammalian cells // Radiat. Res. 1998. № 150. C. S80−91.
- Gescher A. Analogs of staurosporine: potential anticancer drugs? // Gen. Pharmacol. 1998. № 31. C. 721−728.
- Miiller M. ΠΈ Π΄Ρ. p53 activates the CD95 (APO-l/Fas) gene in response to DNA damage by anticancer drugs // J. Exp. Med. 1998. № 188. C. 2033−2045.
- Zhao J.H., Reiske H., Guan J.L. Regulation of the cell cycle by focal adhesion kinase // J. Cell Biol. 1998. № 143. C. 1997−2008.
- Krammer P.H. CD95(APO-l/Fas)-mediated apoptosis: live and let die // Adv. Immunol. 1999. № 71. C. 163−210.
- Alice in caspase land. A phylogenetic analysis of caspases from worm to man ΠΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΡΠΉ ΡΠ΅ΡΡΡΡ. URL: http://www.nature.com/cdd/journal/v9/n4/full/440 0989a.html (Π²ΡΠ·Π²Π°Π½ΠΎ: 18.02.2010).
- DTP Primary Anti-cancer Drug Screening Activities ΠΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΡΠΉ ΡΠ΅ΡΡΡΡ. URL: http://dtp.nci.nih.gov/branches/btb/hfa.html (Π²ΡΠ·Π²Π°Π½ΠΎ: 02.03.2010).
- Bashir Π’., Pagano M. Cdkl: the dominant sibling of Cdk2 // Nat Cell Biol. 2005. № 7. C. 779−781.
- Benson F.E., Baumann P., West S.C. Synergistic actions of Rad51 and Rad52 in recombination and DNA repair //Nature. 1998. № 391. C. 401−404.
- Birk Π. ΠΈ Π΄Ρ. Cytoplasmic vacuolization responses to cytopathic bovine viral diarrhoea virus // Virus Research. 2008. № 132. C. 76−85.
- Brana M. h zip. Intercalators as Anticancer Drugs // Current Pharmaceutical Design. 2001. № 7. C. 1745−1780.
- Carini R. h zip. Alteration of Na+ homeostasis as a critical step in the development of irreversible hepatocyte injury after adenosine triphosphate depletion // Hepatology. 1995. № 21. C. 1089−1098.
- Clarke P., Clarke S. Nineteenth century research on naturally occurring cell death and related phenomena// Anat Embryol. 1996. № 193.
- Giaccia A.J., Kastan M.B. The complexity of p53 modulation: emerging patterns from divergent signals // Genes & Development. 1998. № 12. C. 2973−2983.
- Ishitani R. h zip. Overexpression of Glyceraldehyde-3-Phosphate Dehydrogenase Is Involved in Low K±Induced Apoptosis but Not Necrosis of Cultured Cerebellar Granule Cells // Molecular Pharmacology. 1997. № 51. C. 542−550.
- Kastan M.B., Bartek J. Cell-cycle checkpoints and cancer // Nature. 2004. № 432. C. 316 323.
- Kroemer G. h zip. Classification of cell death: recommendations of the Nomenclature, Committee on Cell Death 2009 // Cell Death Differ. 2008. № 16. C. 3−11.
- Krokan H., Wist E., Krokan R.H. Aphidicolin inhibits DNA synthesis by DNA polymerase {alpha} and isolated nuclei by a similar mechanism // Nucl. Acids Res. 1981. № 9. C. 4709-. 4719.
- Lee J., Paull T.T. Direct Activation of the ATM Protein Kinase by the Mrel 1/Rad50/Nbsl Complex // Science. 2004. № 304. C. 93−96.
- Luthi A.U., Martin S J. The CASBAH: a searchable database of caspase substrates // Cell Death Differ. 2007. № 14. C. 641−650.
- Malumbres M., Barbacid M. Mammalian cyclin-dependent kinases // Trends in Biochemical Sciences. 2005. № 30. C. 630−641.
- Malumbres M. h ap- Mammalian Cells Cycle without the D-Type Cyclin-Dependent Kinases Cdk4 and Cdk6 // Cell. 2004. № 118. C. 493−504.
- Martin A. Cell cycle inhibition and tumor suppression by p21Cipl and p27Kipl are independent of Cdk2 // Cancer Cell. 2005. № 7. C. 591−598.
- Morissette G., Lodge R., Marceau F. Intense pseudotransport of a cationic drug mediated by vacuolar ATPase: Procainamide-induced autophagic cell vacuolization // Toxicology and Applied Pharmacology. 2008. № 228. C. 364−377.
- Murphy M. Delayed early embryonic lethality following disruption of the murine cyclin A2 gene//Nature Genet. 1997. № 15. C. 83−86.
- Oppenheim R.W. h Ap. Programmed Cell Death of Developing Mammalian Neurons after Genetic Deletion of Caspases//J. Neurosci. 2001. № 21. C. 4752−4760.
- Padanilam B.J. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis // Am J Physiol Renal Physiol. 2003. № 284. C. F608−627.
- Ribes-Zamora A. m Ap. Distinct faces of the Ku heterodimer mediate DNA repair and telomeric functions //Nat Struct Mol Biol. 2007. № 14. C. 301−307.
- Santamaria D. h Ap. Cdkl is sufficient to drive the mammalian cell cycle // Nature. 2007. № 448. C. 811−815.
- Setiembre C. h ap- Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiency // Proceedings of the National Academy of Sciences. 2007. № 104. C. 4506−4511.
- Shen Z.Y. h Ap. Specific interactions between the human Rad51 and Rad52 proteins. // J. Biol. Chem. 1996. № 271. C. 148−152.
- Shiloh Y. ATM and related protein kinases: safeguarding genome integrity // Nat Rev Cancer. 2003. № 3. C. 155−168.
- Shiloh Y. The ATM-mediated DNA-damage response: taking shape // Trends in Biochemical Sciences. 2006. № 31. C. 402−410.
- Tinel A. The PIDDosome, a Protein Complex Implicated in Activation of Caspase-2 in- Response to Genotoxic Stress // Science. 2004. № 304. C. 843−846.
- Tsutsui T. h Ap. Targeted Disruption of CDK4 Delays Cell Cycle Entry with Enhanced p27Kipl Activity // Mol. Cell. Biol. 1999. № 19. C. 7011−7019.
- Vande Velde C. h Ap. BNIP3 and Genetic Control of Necrosis-Like Cell Death through the Mitochondrial Permeability Transition Pore // Mol. Cell. Biol. 2000. № 20. C. 5454−5468.
- Vogt C. Untersuchungen tiber die Entwicklungsgeschichte der Geburtshelferkroete (Alytes obstetricans). Solothurn: Jent und Gassmann, 1842.
- Yeh W. h Ap. FADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of Apoptosis // Science. 1998. № 279. C. 1954−1958.